黑料官网

header-logo
GettyImages-609179959-hero
Hematology and Oncology
Peiman Hematti, MD

Peiman Hematti, MD

Professor; Director, Cell Therapy Lab

Contact Information

Education

MD, Tehran University of Medical Sciences, Tehran, 1990
Residency, Internal Medicine/Pediatrics, Cleveland Clinic Foundation, Cleveland, OH, 1995-1999
Clinical Fellowship, Hematology, NHLBI, National Institutes of Health, Bethesda, MD, 1999-2001
Research Fellowship, Laboratory of Molecular Hematopoiesis, NHLBI, NIH, Bethesda, MD, 2001-2004

Biography

Specialties

  • Internal Medicine
  • Pediatrics
  • Hematology

Research Areas of Interest

  • Cell- and Tissue-Based Therapy
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells
  • Macrophages
  • Stem Cell Transplantation

Research Experience

  • Bone Marrow Cells
  • Bone Marrow Transplantation
  • Cell- and Tissue-Based Therapy
  • Clinical Trials, Phase I as Topic
  • Coculture Techniques
  • Exosomes
  • Extracellular Vesicles
  • Fibroblasts
  • Graft vs Host Disease
  • Hematopoiesis
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation

Clinical Expertise

  • Bone Marrow Transplantation
  • Cell- and Tissue-Based Therapy
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal Stem Cell Transplantation
  • Peripheral Blood Stem Cell Transplantation
  • Stem Cell Transplantation
  • Transplantation, Autologous
  • Whole-Body Irradiation

Publications

  • (Mirza AS, Hosing C, Foss F, Kim S, Moskop A, Oloyede T, Abid MB, Afrough A, Ahmed S, Badar T, Barba P, Bhatt VR, Brown VI, Dahiya S, Deol A, Epperla N, Ganguly S, Grover NS, Hashmi H, Hashmi S, Hematti P, Hildebrandt GC, Hill JM Jr, Hossain NM, Ibrahim U, Johnson PC, Kharfan-Dabaja MA, Krem MM, Lekakis LJ, Maziarz RT, Murthy HS, Riedell PA, Salas MQ, Shouse G, Strouse C, Thakar MS, Turtle CJ, Woolfrey A, Wudhikarn K, Yared JA, Pasquini MC, Gowda L.) Blood Neoplasia. 2026 May;3(2):100187 PMID: 41867486 PMCID: PMC12999346 03/23/2026

  • (Rangarajan HG, Chellapandian D, Atshan R, Ahn KW, Kumar S, Knight TE, Leung W, Ganguly S, Williams KM, Shah NN, Bhatt NS, Lust H, Prestidge T, Brown VI, Hayashi RJ, Choe M, Saad A, Bidgoli A, Thakar MS, Wirk B, MacMillan ML, Lalefar NR, Hematti P, Schultz KR, Phillips CL, Mehta PA, Qayed M, Sharma A, Broglie L, Satwani P.) Transplant Cell Ther. 2026 May;32(5):580.e1-580.e18 PMID: 41468926 PMCID: PMC12892929 SCOPUS ID: 2-s2.0-105028756101 12/31/2025

  • (Hoeve ESV, Alzoubi B, Rumble ME, Cadmus-Bertram L, Juckett MB, Callander NS, Hematti P, Costanzo ES.) J Pain Symptom Manage. 2026 Apr 16 PMID: 42000061 PMCID: PMC13215335 SCOPUS ID: 2-s2.0-105038855692 04/19/2026

  • (Memon AA, Said I, Norenberg E, Frei A, Foeckler J, Sun F, Dwinell MB, Lochhead RB, Bruening J, Akakpo K, Massey B, Wong SJ, Hematti P, Kearl TJ, Awan MJ, Himburg HA, Zenga J.) Cancer Immunol Immunother. 2026 Apr 15;75(5) PMID: 41984232 PMCID: PMC13083680 SCOPUS ID: 2-s2.0-105035819105 04/15/2026

  • (Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Oloyede T, Awan FT, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Farooq U, Foglesong J, Ganguly S, Hematti P, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, McGuirk JP, Mead E, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Geethakumari PR, Riedell PA, Saber W, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse C, Turtle CJ, Vallurupalli A, Wudhikarn K, Pasquini MC, Ahmed S, Sorror M.) Blood Adv. 2026 Jan 13;10(1):217-227 PMID: 40811818 PMCID: PMC12811452 SCOPUS ID: 2-s2.0-105027158017 08/14/2025

  • (Kink JA, Forsberg MH, Krismer DM, Thickens AS, Chinnadurai R, Chen AS, Chacko DJ, Graham M, Hematti P, Capitini CM.) Stem Cells Transl Med. 2026 Jan 09;15(1) PMID: 41510819 PMCID: PMC12784198 SCOPUS ID: 2-s2.0-105027041495 01/09/2026

  • (Said I, Awan MJ, Wong SJ, Memon AA, Kearl T, Hematti P, Massey B, Bruening J, Akakpo K, Zenga J, Himburg HA.) Int J Radiat Oncol Biol Phys. 2026 Jan 01;124(1):190-193 PMID: 41391923 PMCID: PMC12939519 SCOPUS ID: 2-s2.0-105024206020 12/15/2025

  • (Pham DL, Kalluri M, Weaver C, Hsu A, Gillette A, Zhao W, Kearl T, Hematti P, Shah N, Skala MC.) bioRxiv. 2025 Nov 16 PMID: 41292840 PMCID: PMC12642466 11/26/2025

  • (Ahmed N, Thiruvengadam SK, Hamadani M, Hu ZH, Grover N, Shadman M, Locke FL, Gerson J, Frank MJ, Budde LE, Wang M, Kim S, Bye M, Kharfan-Dabaja MA, Sauter C, Hematti P, Turtle CJ, Ahmed S, Moskop A, Logan B, Nunes A, Dalton D, Kloos I, Lee D, Xu H, Pasquini MC, Herrera AF.) Blood Adv. 2025 Oct 28;9(20):5382-5396 PMID: 40706035 PMCID: PMC12597645 SCOPUS ID: 2-s2.0-105022684848 07/24/2025

  • (Tu GC, Abedi F, Chang AY, Shen X, Soleimani M, Araujo I, Jung R, Kwon J, Anwar KN, Arabpour Z, Mahmud N, Tu EY, Dana R, Hematti P, Joslin CE, Djalilian AR.) Ocul Surf. 2025 Oct;38:8-13 PMID: 40414287 SCOPUS ID: 2-s2.0-105006813588 05/26/2025

  • (Tu GC, Ghalibafan S, Abedi F, Joslin CE, Dana R, Hematti P, Djalilian AR.) Stem Cells. 2025 Sep 17;43(10) PMID: 40632601 PMCID: PMC12471346 SCOPUS ID: 2-s2.0-105017418063 07/09/2025

  • (Zenga J, Awan MJ, Frei A, Foeckler J, Kuehn R, Kasprzak J, Massey B, Bruening J, Akakpo K, Shukla M, Wong SJ, Mathison AJ, Wendt Andrae J, Hunt B, Puzyrenko A, Jin VX, Memon AA, Villarreal Espinosa O, Chen F, Shaheduzzaman M, Kearl T, Hematti P, Himburg HA.) Nat Commun. 2025 Jul 01;16(1):5660 PMID: 40593620 PMCID: PMC12219838 SCOPUS ID: 2-s2.0-105009625716 07/02/2025

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.